Loading...
| Name: | Description: | Size: | Format: | |
|---|---|---|---|---|
| 145.78 KB | Adobe PDF |
Advisor(s)
Abstract(s)
A Perturbação de Hiperatividade e Défice de Atenção (PHDA) é uma doença do neurodesenvolvimento cujos sintomas e neurobiologia podem conferir risco aumentado de para o consumo abusivo de substâncias tóxicas incluindo o álcool.
A Perturbação de Uso de Álcool (PUA) e PHDA partilham fatores de risco e vários mecanismos neurobiológicos, não sendo de admirar que surjam frequentemente em comorbilidade familiar e no mesmo indivíduo. Por isso, recomenda-se o screening de PHDA nos doentes que procuram ajuda por abuso de substâncias e mesmo PUA.
Nos doentes com PHDA, a PUA inicia-se mais precocemente e associa-se a piores outcomes clínicos e de tratamento. O tratamento da PUA em comorbilidade com a PHDA deve englobar preferencialmente uma abordagem fármaco e psicoterapêutica dirigida a ambas as patologias
Attention Deficit and Hyperactivity Disorder (ADHD) is a disease of neurodevelopment which symptoms and neurobiology may raise the risk of toxic substance abuse, including alcohol abuse. ADHD and Alcohol Use Disorder (AUD) share risk factors and several neurobiological mechanisms, and are frequently found in comorbility, whether in the same person or within family members. Therefore, the screening of ADHD is recommended in patients who present to healthcare services with Substance and Alcohol Use Disorders. In people with ADHD, AUD is associated with earlier age and worst clinical and treatment outcomes. Treatment plan should preferably include both pharmacologic and psychotherapeutic strategies directed at both disorders
Attention Deficit and Hyperactivity Disorder (ADHD) is a disease of neurodevelopment which symptoms and neurobiology may raise the risk of toxic substance abuse, including alcohol abuse. ADHD and Alcohol Use Disorder (AUD) share risk factors and several neurobiological mechanisms, and are frequently found in comorbility, whether in the same person or within family members. Therefore, the screening of ADHD is recommended in patients who present to healthcare services with Substance and Alcohol Use Disorders. In people with ADHD, AUD is associated with earlier age and worst clinical and treatment outcomes. Treatment plan should preferably include both pharmacologic and psychotherapeutic strategies directed at both disorders
Description
Keywords
Álcool Défice de Atenção Perturbação de Uso de Álcool Perturbação de Hiperatividade Estimulantes HJM PSIQ
Pedagogical Context
Citation
Rev Port Alcoologia. 2024; 5(1):16-24